Abstract
Background While antipsychotic-free schizophrenia patients showed a high degree of within-subject variability in dopamine D 2 receptor density over 6–24 months, no study has examined the long-term stability of D 2 receptor measures in medicated patients. Methods Four schizophrenia patients receiving a stable dose of risperidone underwent [ 11C]raclopride positron emission tomography scans on two occasions 5–14 months apart. Results Plasma risperidone levels were found to be consistent between scans, and consistencies of nondisplaceable D 2 binding potential and D 2 occupancy were good. Conclusions The finding supports the validity of quantification of D 2 receptor binding in longitudinal PET studies of medicated patients with schizophrenia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
